Search - tctmd.com

Displaying 61 - 80 of 165

Sort: Relevancy | Date

Presentation TCT 2014

Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension: Vascular Dynamics

Presenter: Daniel Burkhoff, Felix Mahfoud, Jose Luis Assad-Morell, Sahil A. Parikh, Mark C. Bates

September 15, 2014

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

Presentation TCT 2014

A Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension (Vascular Dynamics)

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Mark C. Bates

September 14, 2014

Presentation TCT 2014

TCT 685: Costs of Periprocedural Complications Among Patients Treated with a Self-Expanding Transcatheter Aortic Valve Prosthesis: Results from the CoreValve US Pivotal Extreme-Risk Study

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Suzanne Baron

September 14, 2014

News Industry News

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

September 13, 2014

News Daily News

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Caitlin E. Cox

August 07, 2014

News Industry News

Sorin Group Announces FDA Approval of Solo Smart – The Next Evolution in Tissue Valve Technology

July 29, 2014

News Daily News

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

Yael L. Maxwell

July 24, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

July 22, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

July 22, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

News Industry News

CardiAQ™ Valve Technologies, Inc. announces that it has obtained a stay of further proceedings in Neovasc Inc.’s pending European patent application covering Transcatheter Mitral Valve Replacement

July 07, 2014

News Daily News

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

July 03, 2014

News Daily News

Se Observa Cierto Empeoramiento a Largo Plazo en los Resultados Favorables de una Serie Inicial de CoreValve

July 03, 2014

Presentation

Three-Year Outcomes after TAVR with the CoreValve Prosthesis

Presenter: Michael Gotzmann

June 30, 2014

News Daily News

Transesophageal Echo Leads to Wrong CoreValve Sizing in Nearly Half of Patients

L.A. McKeown

June 24, 2014

News Industry News

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

June 06, 2014

News Industry News

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

June 04, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

Advertisement

Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension: Vascular Dynamics

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

A Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension (Vascular Dynamics)

TCT 685: Costs of Periprocedural Complications Among Patients Treated with a Self-Expanding Transcatheter Aortic Valve Prosthesis: Results from the CoreValve US Pivotal Extreme-Risk Study

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Sorin Group Announces FDA Approval of Solo Smart – The Next Evolution in Tissue Valve Technology

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

CardiAQ™ Valve Technologies, Inc. announces that it has obtained a stay of further proceedings in Neovasc Inc.’s pending European patent application covering Transcatheter Mitral Valve Replacement

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

Se Observa Cierto Empeoramiento a Largo Plazo en los Resultados Favorables de una Serie Inicial de CoreValve

Three-Year Outcomes after TAVR with the CoreValve Prosthesis

Transesophageal Echo Leads to Wrong CoreValve Sizing in Nearly Half of Patients

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content